Investigating miRNA-related Pathways Contributing to Kidney Cancer Pathogenesis

Peter Yousef1, Rania Ibrahim1, Carl Boulos1

  • 1Department of Laboratory Medicine, and the Keenan Research Centre for Biomedical Science at the Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, ON, Canada.

Anticancer Research
|April 30, 2022
PubMed
Abstract

Insights

This study reveals complex interactions between transcription factors (TFs) and microRNAs (miRNAs) in renal cell carcinoma. Certain TFs correlate with tumor prognosis, suggesting potential as biomarkers for aggressive kidney cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Renal cell carcinoma (RCC) is a prevalent global cancer.
  • Understanding tumor pathogenesis is crucial for developing effective treatments.
  • MicroRNAs (miRNAs) and transcription factors (TFs) play significant roles in cancer development and progression.

Purpose of the Study:

  • To elucidate the intricate interactions within the transcription factor-microRNA (TF-miRNA) axis in kidney cancer.
  • To identify specific TFs that regulate miRNA expression in renal cell carcinoma.
  • To explore the prognostic significance of these TF-miRNA interactions.

Main Methods:

  • Utilized public databases (ChipBase, GENT, cBioPortal) to identify miRNA-TF interactions.
  • Investigated TFs binding to promoters of dysregulated miRNAs in RCC.
  • Assessed the prognostic value of identified TFs in renal cancer.

Main Results:

  • Identified key TFs (HNF-4α, E2F4, STAT1, SP1, GATA6, NFκB) interacting with RCC-associated miRNAs (miR-200c, miR-15a, miR-146b, miR-155, miR-223).
  • Observed positive correlations between TF expression and their targeted miRNAs.
  • Discovered complex interaction patterns, including TFs affecting multiple miRNAs simultaneously.

Conclusions:

  • TF-miRNA interactions in renal cell carcinoma are complex and multifaceted.
  • Expression levels of identified TFs correlate with RCC prognosis and can serve as potential biomarkers for aggressive disease.
  • Targeting these TFs offers therapeutic potential for modulating gene and miRNA expression in RCC treatment.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.0K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K